The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
telephone:
01413302393
email:
Nicola.Britton@glasgow.ac.uk
LEVEL 4 , ROOM 438, ICAMS, GCRC, Glasgow, G12 8TA
Nicklin, S. A. et al. (2026) Evolution and production of a clinical-grade adenovirus expressing the transgene tissue inhibitor of metalloproteinase-3 (TIMP-3) through genome engineering. Pharmaceutical Bioprocessing, (Accepted for Publication)
Work, L.M. et al. (2006) Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses. Molecular Therapy, 13(4), pp. 683-693. (doi: 10.1016/j.ymthe.2005.11.013)
Nicklin, S. A. et al. (2026) Evolution and production of a clinical-grade adenovirus expressing the transgene tissue inhibitor of metalloproteinase-3 (TIMP-3) through genome engineering. Pharmaceutical Bioprocessing, (Accepted for Publication)
Work, L.M. et al. (2006) Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses. Molecular Therapy, 13(4), pp. 683-693. (doi: 10.1016/j.ymthe.2005.11.013)